DCGI cracks down on indirect promotion of weight-loss prescription drugs
New Delhi: The Drugs Controller General of India (DCGI) has directed all pharmaceutical manufacturers and importers to immediately stop surrogate, or indirect, promotion of prescription drugs, particularly targeting new weight-loss and metabolic disorder …